At the Biomarkers team, we work closely with researchers all over Europe to help them find the right tools to discover new diagnostic and/or prognostic biomarkers. This is a trend in research nowadays. Horizon 2020 programs aiming at discovering new biomarkers have received major funding in 2014 and will continue to do so in 2015. This follows the path set for personalised medicine to improve the quality of life of patients all over the world.

However, research on biomarkers is not always easy. Getting the clinical samples or the samples from animal models requires a big deal of coordination. Choosing the right tool to unravel the molecular mechanisms behind a disease or its response to treatment is another stone on the way. And then… interpreting the results can be time-consuming too.